RxDoctor Payments Data

Ray Davis

Pediatric Allergy/Immunology · Saint Louis, MONPI 1821037334

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 41.3% of the total. Reporting peaked in 2021 at $6,190 and has fallen 86.7% since, to $824 in 2025.

$14,486in general payments, 2019–2025

Across 193 payments — averaging $75.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$6K
  • Sanofi$3K
  • Shire North American Group Inc$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • AstraZeneca$842
  • GSK$384
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$6,51945%
  • Speaking & faculty fees$1,68012%
  • Travel & lodging$1,57511%
  • Food & beverage$4,71233%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,486 in reported general payments places this provider in the 85th percentile of 22 pediatric allergy/immunology providers in Missouri.

See all pediatric allergy/immunology providers in Missouri

Other pediatric allergy/immunology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →